Beijing, China

Dujia Jin

USPTO Granted Patents = 1 


 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):

Title: **Innovator Spotlight: Dujia Jin and His Contributions to Insulin-Lipid Complexes**

Introduction

Dujia Jin, an accomplished inventor based in Beijing, China, has made significant strides in the field of biochemistry. With a focus on the synthesis of insulin-lipid complexes, his work aims to enhance the delivery and effectiveness of insulin for diabetes treatment. He is affiliated with the Chinese Academy of Sciences, where he collaborates with fellow researchers to push the boundaries of innovation in medical technologies.

Latest Patents

Dujia Jin holds a patent for an "Insulin-lipid complex, preparation method therefor, and preparation thereof." This invention provides a method for preparing an insulin-lipid complex by combining insulin with lipid material in an organic solvent system that includes a low boiling point acid, followed by a drying process. The specific mass ratio of insulin to lipid material ranges from 1:3 to 1:20, allowing for tailored formulations. Additionally, the patent includes the creation of an oil solution of the insulin-lipid complex and vesicles containing insulin, presenting new possibilities for insulin delivery.

Career Highlights

Jin's career at the Chinese Academy of Sciences is marked by his dedication to research and innovation in drug delivery systems. His work is aligned with the critical need for more effective diabetes treatment options, demonstrating his commitment to improving patient outcomes.

Collaborations

Throughout his career, Dujia Jin has had the pleasure of working with talented colleagues such as Yuling Liu and Cuiping Zhou. These collaborations have resulted in the sharing of valuable insights and techniques in their joint pursuit of advancing biotechnological solutions.

Conclusion

Dujia Jin exemplifies the spirit of innovation in the biomedical field. His patented work on insulin-lipid complexes not only showcases his creative prowess but also his dedication to addressing critical health challenges. As he continues to collaborate with esteemed professionals and contribute to scientific advancements, Jin is poised to influence the landscape of diabetes treatment significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…